top of page
Congratulations to our portfolio company Alveus Therapeutics on launching the Phase 2 PRESERVE trial, an important step toward helping patients sustain weight loss over the long term:
Sep 14, 2026
bottom of page
Congratulations to our portfolio company Alveus Therapeutics on launching the Phase 2 PRESERVE trial, an important step toward helping patients sustain weight loss over the long term:
Sep 14, 2026